- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ensuring Access to Generic Medications
Generic drugs offer treatment options that are as safe and effective as brand name drugs while also helping lower costs for both patients and health systems. It's estimated that over the last 10 years, generics have saved Americans $1.5 trillion
Generic drugs offer treatment options that are as safe and effective as brand name drugs while also helping lower costs for both patients and health systems. It's estimated that over the last 10 years, generics have saved Americans $1.5 trillion. However, there are still many off-patent medications that have few or no generic alternatives. And even when generics do exist, there are instances where the generic receives steep price increases or experiences shortages.
During this podcast, we speak with Ron Piervincenzi, PhD, chief executive officer (CEO) of the United States Pharmacopeia, and Martin Van Trieste, CEO of Civica Rx, about these issues and what their companies are doing to address them.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Health Systems Move Forward in Establishing Nonprofit Generic Drug Company
Substituting Brand-Name Combinations for Generics Could Have Saved Medicare $925 Million in 2016
FDA Plan to Boost Drug Competition Includes Expedited Generic Approval Pathway
Costs for Seniors Jump as Generic Drugs Move to Higher Formulary Tiers in Part D Plans
Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug Industries
To read more on generics:
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
